May-Thurner syndrome: modern methods of diagnosis and treatment
D. G. Gitelson,
A. G. Faibushevich,
D. A. Maximkin,
G. I. Veretnik,
V. Yu. Baranovich,
E. A. Gitelzon,
M. N. Astahov,
M. P. Izvekov,
A. E. Vasiliev,
K. I. Danishian https://doi.org/10.17802/2306-1278-2021-10-1-89-96
Abstract
May-Turner syndrome is a condition where the left common iliac vein is compressed between the lumbar spine and the overlying right common iliac artery. Left iliac vein compression is common (up to 24%) in the general population, but clinical manifestations occur in a few patients. This syndrome should be considered in case of unexplained edema of the left lower extremity since routine duplex ultrasound does not possess optimal sensitivity and specificity in the study of the iliac veins and the inferior vena cava. Intravascular ultrasound is the most accurate diagnostic method. However, the advent of computed tomography angiography and magnetic resonance angiography providing high-quality images of the vasculature have become a promising alternative to invasive intravascular ultrasound. Treatment for May-Turner syndrome usually involves stenting of the left common iliac vein along with medical therapy, including antithrombotic (anticoagulant and antiplatelet) therapy combined with phlebotonics. Our review reports modern methods of diagnosis and treatment of May-Turner syndrome.
About the Authors
D. G. Gitelson
Peoples' Friendship University of Russia; National Research Center for Hematology
Russian Federation
Competing Interests:
Russian Federation
Gitelson Daniel G. - M.D., a Ph.D. student at the Surgical Department, Medical Institute, Peoples' Friendship University of Russia; an interventional cardiologist, cardiovascular surgeon at the National Hematology Research Center.
6, Miklukho-Maklaya St., Moscow, 117198; 4, Noviy Zykovskii Dr., Moscow, 125167.
Competing Interests:
No conflict of interest.
A. G. Faibushevich
Peoples' Friendship University of Russia
Russian Federation
Competing Interests:
Russian Federation
Faibushevich Alexander G. - M.D., Ph.D., the Head of the Surgical Department, Medical Institute, Peoples' Friendship University of Russia.
6, Miklukho-Maklaya St., Moscow, 117198.
Competing Interests:
No conflict of interest.
D. A. Maximkin
Peoples' Friendship University of Russia
Russian Federation
Competing Interests:
Russian Federation
Maximkin Daniel A. - M.D., Ph.D., Associate Professor at the Surgical Department, Medical Institute, Peoples' Friendship University of Russia.
6, Miklukho-Maklaya St., Moscow, 117198.
Competing Interests:
No conflict of interest.
G. I. Veretnik
Peoples' Friendship University of Russia
Russian Federation
Competing Interests:
Russian Federation
Veretnik Galina I. - M.D., Ph.D., Curriculum Director of the Surgical Department, Medical Institute, Peoples' Friendship University of Russia.
6, Miklukho-Maklaya St., Moscow, 117198.
Competing Interests:
No conflict of interest.
V. Yu. Baranovich
Peoples' Friendship University of Russia
Russian Federation
Competing Interests:
Russian Federation
Baranovich Vladislav Yu. - M.D., Ph.D., Associate Professor at the Surgical Department, Medical Institute, Peoples' Friendship University of Russia.
6, Miklukho-Maklaya St., Moscow, 117198.
Competing Interests:
No conflict of interest.
E. A. Gitelzon
Peoples' Friendship University of Russia
Russian Federation
Competing Interests:
Russian Federation
Gitelzon Ekaterina A. - M.D., a Ph.D. student at the Surgical Department, Medical Institute, Peoples' Friendship University of Russia.
6, Miklukho-Maklaya St., Moscow, 117198.
Competing Interests:
No conflict of interest.
M. N. Astahov
Zhukovskiy City Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Astahov Maxim N. - M.D., an interventional cardiologist at the Zhukovskiy City Clinical Hospital.
1, Frunze St., Zhukovskiy, 140180.
Competing Interests:
No conflict of interest.
M. P. Izvekov
Zhukovskiy City Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Izvekov Michael P. - M.D., an interventional cardiologist at the Zhukovskiy City Clinical Hospital.
1, Frunze St., Zhukovskiy, 140180.
Competing Interests:
No conflict of interest.
A. E. Vasiliev
National Research Center for Hematology
Russian Federation
Competing Interests:
Russian Federation
Vasiliev Alexander E. - M.D., Ph.D., an interventional cardiologist at the National Hematology Research Center.
4, Noviy Zykovskii Dr., Moscow, 125167.
Competing Interests:
No conflict of interest.
K. I. Danishian
National Research Center for Hematology
Russian Federation
Competing Interests:
Russian Federation
Danishian Karen I. - M.D., Ph.D., the Head of the Surgical Department, National Hematology Research Center.
4, Noviy Zykovskii Dr., Moscow, 125167.
Competing Interests:
No conflict of interest.
References
1. May R., Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957; 8: 419-427.
2. Cockett F.B, Thomas M.L. The Iliac Compression Syndrome. Br J Surg. 1965;52(10):816-21. doi: 10.1002/bjs.1800521028.
3. Kibbe M.R., Ujiki M., Goodwin A.L., Eskandari M., Yao J., Matsumura J. Iliac vein compression in an asymptomatic patient population. J Vasc Surg. 2004; 39: 937-943.
4. Taheri S.A., Williams J., Powell S., Cullen J., Peer R., Nowakowski P., et al. Iliocaval compression syndrome. Am J Surg. 1987; 154: 169-172.
5. Knuttinen M.G., Naidu S., Oklu R., Kriegshauser S., Eversman W., Rotelliniet L., et al. May-Thurner: diagnosis and endovascular management. Cardiovasc Diagn Ther. 2017; 7(Suppl 3): S159-S164. doi: 10.21037/cdt.2017.10.14
6. Kahn S.R., Solymoss S., Lamping D.L., Abenhaim L. Long-term outcomes after deep vein thrombosis: postphlebitic syndrome and quality of life. J Gen Intern Med. 2000; 15: 425429. doi: 10.1046/j.1525-1497.2000.06419.x.
7. Van Korlaar I., Vossen C., Rosendaal F., Cameron L., Bovill E., Kaptein A. Quality of life in venous disease. Thromb Haemost. 2003; 90: 27-35.
8. Lubberts B., Pereira P., Kabrhel C., Kuter D.J., DiGiovanni C.W. What is the effect of venous thromboembolism and related complications on patient reported health-related quality of life? A meta-analysis. Thromb Haemost. 2016; 116: 417-431. doi: 10.1160/TH16-02-0152.
9. Kahn S.R., Ducruet T., Lamping D.L., Arsenault L., Miron M.J., Roussin A., et al. Prospective evaluation of health-related quality of life in patients with deep venous thrombosis. Arch Intern Med. 2005; 165: 1173-1178. doi: 10.1001/archinte.165.10.1173.
10. Catarinella F.H., Nieman M.A., de Wolf I.M., Toonder I.M., de Graaf R., Wittens C.H.A. Quality-of-life in interventionally treated patients with post-thrombotic syndrome. Phlebology. 2015; 30(Suppl. 1): 89-94. doi: 10.1177/0268355515569431.
11. Labropoulos N., Borge M., Pierce K., Pappas P.J. Criteria for defining significant central vein stenosis with duplex ultrasound. J Vasc Surg. 2007; 46(1): 101-107. doi: 10.1016/j.jvs.2007.02.062.
12. Brinegar K.N., Sheth R.A., Khademhosseini A., Bautista J., Oklu R. Iliac vein compression syndrome: clinical, imaging and pathologic findings. World J Radiol. 2015; 7: 375-381. doi: 10.4329/wjr.v7.i11.375.
13. Zucker E.J., Ganguli S., Ghoshhajra B.B., Gupta R., Prabhakar A.M. Imaging of venous compression syndromes. Therapy. 2016;6: 519-532. doi: 10.21037/cdt.2016.11.19.
14. White J.M., Comerota A.J. Venous compression syndromes. Vasc Endovascular Surg. 2017; 51: 155-168. doi: 10.1177/1538574417697208.
15. Birn J., Vedantham S. May-Thurner syndrome and other obstructive iliac vein lesions: meaning, myth, and mystery. Vasc Med. 2014; 20: 74-83. doi: 10.1177/1358863X14560429.
16. Fox A.J., Symons S.P., Aviv R.I. Contrast-induced Nephropathy and Dehydration. Can Assoc Radiol J. 2013;64(3):275. doi: 10.1016/j.carj.2012.12.004.
17. Shammas N.W., Shammas G.A., Jones-Miller S., Radaideh Q., Winter A.R., Shammaset A.N., et al. Predicting iliac vein compression with computed tomography angiography and venography: correlation with intravascular ultrasound. J Invasive Cardiol. 2018; 30: 452-455.
18. Shammas N.W., Rachwan R.J., Daher G., Bou Dargham B. Double inferior vena cava and its implications during endovascular and surgical interventions: a word of caution. J Invasive Cardiol. 2017; 29: 51-53.
19. Park J.Y., Ahn J.H., Jeon Y.S., Cho S.G., Kim J.Y., Hong K.C. Iliac vein stenting as a durable option for residual stenosis after catheter- directed thrombolysis and angioplasty of iliofemoral deep vein thrombosis secondary to May-Thurner syndrome. Phlebology. 2014; 29: 461-470. doi: 10.1177/0268355513491724.
20. Raju S., Ward M. Jr., Kirk O.A. Modification of iliac vein stent technique. Ann Vasc Surg. 2014; 28: 1485-1492. doi: 10.1016/j.avsg.2014.02.026.
21. Neglen P., Hollis K.C., Olivier J., Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg. 2007; 46: 979-990. doi: 10.1016/j.jvs.2007.06.046.
22. Lichtenberg M., de Graaf R., Stahlhoff W.F., Ozkapi A., Simon M., Breuckmann F. Patency rates, safety and clinical results of the sinus-Obliquus venous stent in the treatment of chronic ilio-femoral venous outflow obstruction - data from the Arnsberg venous registry. Vasa. 2019; 48(3): 270-275. doi: 10.1024/0301-1526/a000772.
23. Stuck A.K., Reich T., Engelberger R.P., Sebastian T., Kucher N. Endovascular treatment of post-thrombotic and non thrombotic iliofemoral venous outflow obstructions with self-expanding nitinol stents. Vasa. 2018; 47(4): 319-325. doi: 10.1024/0301-1526/a000697.
24. Dabir D., Feisst A., Thomas D., Luetkens J.A., Meyer C., Kardulovic A., et al. Physical properties of venous stents: an experimental comparison. Cardiovasc Intervent Radiol. 2018; 41: 942-950. doi: 10.1007/s00270-018-1916-1.
25. Lichtenberg M., de Graaf R., Stahlhoff W.F., Ozkapi A., Simon M., Breuckmann F. Venovo venous stent in the treatment of non-thrombotic or post-thrombotic iliac vein lesions - shortterm results from the Arnsberg venous registry. Vasa. 2019; 48(2): 175-180. doi: 10.1024/0301-1526/a000763.
26. Razavi M.K., Black S., Gagne P., Chiacchierini R., Nicolini P., Marston W. Pivotal Study of Endovenous Stent Placement for Symptomatic Iliofemoral Venous Obstruction. Circ Cardiovasc Interv. 2019; 12(12): e008268. doi: 10.1161/CIRCINTERVENTIONS.119.008268.
27. Kwak H.S., Han Y.M., Lee Y.S., Jin G.Y., Chung G.H. Stents in common iliac vein obstruction with acute ipsilateral deep venous thrombosis: early and late results. J Vasc Interv Radiol. 2005; 16: 815-822. doi: 10.1097/01.RVI.0000157690.91690.38.
28. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., Carta V., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1-7. doi: 10.7326/0003-4819-125-1-199607010-00001.
29. Shi Y., Shi W., Chen L., Gu J. A systematic review of ultrasound-accelerated catheter-directed thrombolysis in the treatment of deep vein thrombosis. J Thromb Thrombolysis. 2018; 45: 440-451. doi: 10.1007/s11239-018-1629-y.
30. Rao A.S., Konig G., Leers S.A., Cho J., Rhee R.Y., Makaroun M.S., et al. Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis: an alternative in patients with contraindications to thrombolysis. J Vasc Surg. 2009; 50: 1092-1098. doi: 10.1016/j.jvs.2009.06.050.
31. Enden T., Haig Y., Klow N.E., Slagsvold C.E., Sandvik L., Ghanima W.,et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial. Lancet. 2012; 379(9810): 31-38. doi: 10.1016/S0140-6736(11)61753-4.
32. Vedantham S., Goldhaber S.Z., Kahn S.R., Julian J., Magnuson E., Jaff M.R., et al. Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J. 2013; 165: 523-530. doi: 10.1016/j.ahj.2013.01.024.
33. Vedantham S., Goldhaber S.Z., Julian J., Kahn S.R., Jaff M.R., Cohen D.J., et al. Pharmacomechanical catheter-directed thrombolysis for Deep-Vein thrombosis. The ATTRACT Trial investigators. New Engl J Med. 2017; 377: 2240-2252. doi: 10.1056/NEJMoa1615066.
34. Wang W., Sun R., Chen Y., Liu C. Meta-analysis and systematic review of percutaneous mechanical thrombectomy for lower extremity deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2018; 6(6): 788-800. doi: 10.1016/j.jvsv.2018.08.002.
35. Li W., Chuanlin Z., Shaoyu M., Yeh C.H., Liqun C., Zeju Z. Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis. Rev Lat Am Enfermagem. 2018; 26: e2990. doi: 10.1590/1518-8345.2309.2990.
36. Oklu R., Wicky S. Catheter-directed thrombolysis of deep venous thrombosis. Semin Thromb Hemost. 2013; 39: 446-451. doi: 10.1055/s-0033-1334142.
37. Comerota A.J., Throm R.C., Mathias S.D., Haughton S., Mewissen M. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg. 2000; 32: 130-137. doi: 10.1067/mva.2000.105664.
38. Hofmann L.V., Kuo W.T. Catheter-directed thrombolysis for acute DVT. Lancet. 2012; 379: 3-4. doi: 10.1016/S0140-6736(11)61875-8
39. Delis K.T., Bjarnason H., Wennberg P.W., Rooke T.W., Gloviczki P. Successful iliac vein and inferior vena cava stenting ameliorates venous claudication and improves venous outflow, calf muscle pump function, and clinical status in post-thrombotic syndrome. Ann Surg. 2007; 245: 130-139. doi: 10.1097/01.sla.0000245550.36159.93.
40. Neglen P., Thrasher T.L., Raju S. Venous outflow obstruction: an underestimated contributor to chronic venous disease. J Vasc Surg. 2003; 38: 879-885. doi: 10.1016/s0741-5214(03)01020-6
Review
For citations:
Gitelson D.G., Faibushevich A.G., Maximkin D.A., Veretnik G.I., Baranovich V.Yu., Gitelzon E.A., Astahov M.N., Izvekov M.P., Vasiliev A.E., Danishian K.I. May-Thurner syndrome: modern methods of diagnosis and treatment. Complex Issues of Cardiovascular Diseases. 2021;10(1):89-96. (In Russ.) https://doi.org/10.17802/2306-1278-2021-10-1-89-96
Views:
2320
